- Investing Ideas
- /
- Hong Kong Biotech Stocks
Hong Kong Biotech Stocks
Results
61
Even though biotechnology stocks can be very risky, they can also offer some of the biggest rewards with huge profits on offer when you find the right one. The companies below all have reasonable balance sheets and value, giving the best chance of finding a gem.
61 companies
Jacobson Pharma
Market Cap: HK$2.4b
Through its subsidiaries, develops, produces, markets, and sells generic drugs and branded healthcare products in Hong Kong, Mainland China, Macau, Singapore, and internationally.
2633
HK$1.25
7D
5.9%
1Y
115.5%
Frontage Holdings
Market Cap: HK$2.3b
A contract research organization, provides laboratory and related services to pharmaceutical, biotechnology, and agrochemical companies.
1521
HK$1.18
7D
-5.6%
1Y
-12.6%
Dawnrays Pharmaceutical (Holdings)
Market Cap: HK$1.7b
An investment holding company, develops, manufactures, and sells non-patented pharmaceutical medicines in Mainland China and internationally.
2348
HK$1.13
7D
-5.0%
1Y
-5.8%
JBM (Healthcare)
Market Cap: HK$1.5b
An investment holding company, engages in the manufacture, marketing, distribution, and sale of branded healthcare and wellness products in Hong Kong, Macau, Mainland China, and internationally.
2161
HK$1.97
7D
13.2%
1Y
111.8%
Hangzhou Jiuyuan Genetic Biopharmaceutical
Market Cap: HK$1.5b
Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd.
2566
HK$5.89
7D
-9.7%
1Y
n/a
Cutia Therapeutics
Market Cap: HK$1.3b
An investment holding company, engages in the research, development, manufacture, and commercialization of scalp diseases and care products, and skin care products in the People’s Republic of China and Hong Kong.
2487
HK$4.44
7D
-22.5%
1Y
-37.1%
Genor Biopharma Holdings
Market Cap: HK$1.0b
A biopharmaceutical company, focuses on developing and commercializing oncology and autoimmune drugs in China and internationally.
6998
HK$2.00
7D
-14.9%
1Y
80.2%
Jilin Province Huinan Changlong Bio-pharmacy
Market Cap: HK$874.0m
Engages in the manufacture and distribution of Chinese medicines and pharmaceutical products in the People’s Republic of China.
8049
HK$1.68
7D
0%
1Y
-4.0%
3D Medicines
Market Cap: HK$842.9m
A biopharmaceutical company, researches, develops, and commercializes oncology products and other drug candidates for the treatment of patients with various cancers in the Mainland China.
1244
HK$3.51
7D
-9.3%
1Y
-37.3%
Zhongzhi Pharmaceutical Holdings
Market Cap: HK$777.2m
An investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical products in the People’s Republic of China.
3737
HK$0.91
7D
1.1%
1Y
-25.4%
Lee's Pharmaceutical Holdings
Market Cap: HK$741.9m
An investment holding company, develops, manufactures, markets, and sells pharmaceutical products primarily in the People's Republic of China.
950
HK$1.22
7D
-12.9%
1Y
3.4%
Pak Fah Yeow International
Market Cap: HK$716.8m
An investment holding, engages in manufacturing, marketing, and distributing healthcare products under the Hoe Hin brand name.
239
HK$2.27
7D
1.8%
1Y
10.2%
JW (Cayman) Therapeutics
Market Cap: HK$582.6m
A clinical stage cell therapy company, engages in the research and development, manufacturing, and marketing of anti-tumor drugs in the People’s Republic of China.
2126
HK$1.48
7D
-9.2%
1Y
-17.3%
Kintor Pharmaceutical
Market Cap: HK$476.3m
A clinical-stage biotechnology company, engages in researching, developing, and commercializing therapeutic drugs for dermatology and tumors indications with the unmet medical needs in the People’s Republic of China.
9939
HK$1.12
7D
-15.2%
1Y
21.7%
Shenzhen Neptunus Interlong Bio-technique
Market Cap: HK$453.1m
Engages in the research and development, manufacturing, and selling of medicines and medical devices in the People’s Republic of China.
8329
HK$0.27
7D
3.8%
1Y
75.3%
Transcenta Holding
Market Cap: HK$448.7m
A clinical stage biopharmaceutical company, engages in the discovery, research, development, manufacture, and commercialization of various drugs for unmet medical needs in the People’s Republic of China and the United States.
6628
HK$1.18
7D
-14.5%
1Y
-15.1%
Austar Lifesciences
Market Cap: HK$415.2m
An investment holding company, engages in the provision of integrated engineering solutions to pharmaceutical manufacturers and research institutes in Mainland China and internationally.
6118
HK$0.81
7D
-5.8%
1Y
-29.6%
Uni-Bio Science Group
Market Cap: HK$394.1m
An investment holding company, researches and develops, manufactures, and sells biological and chemical pharmaceutical products to treat human diseases in the People’s Republic of China.
690
HK$0.067
7D
-2.9%
1Y
-22.1%
Wai Yuen Tong Medicine Holdings
Market Cap: HK$376.9m
An investment holding company, engages in production and sale of Chinese and western pharmaceuticals and health food products in Mainland China and Hong Kong.
897
HK$0.34
7D
-6.8%
1Y
38.8%
Modern Chinese Medicine Group
Market Cap: HK$204.0m
An investment holding company, engages in the production and sale of proprietary Chinese medicines for elderlies and middle aged in the People's Republic of China.
1643
HK$0.35
7D
16.4%
1Y
10.9%
PuraPharm
Market Cap: HK$197.5m
An investment holding company, engages in research, development, production, and sale of concentrated Chinese medicine granule (CCMG) and Chinese healthcare products in Hong Kong, Mainland China, and internationally.
1498
HK$0.49
7D
-10.0%
1Y
-37.3%
Kontafarma China Holdings
Market Cap: HK$134.1m
An investment holding company, engages in the manufacture and sale of prescription drugs in Mainland China, Singapore, Taiwan, and internationally.
1312
HK$0.025
7D
-7.4%
1Y
-24.2%
Extrawell Pharmaceutical Holdings
Market Cap: HK$112.3m
An investment holding company, develops, manufactures, markets, distributes, and sells pharmaceutical products in the People’s Republic of China and Hong Kong.
858
HK$0.047
7D
9.3%
1Y
56.7%
China Regenerative Medicine International
Market Cap: HK$109.5m
An investment holding company, engages in the provision of healthcare products and services in Hong Kong and the People’s Republic of China.
8158
HK$0.29
7D
-7.9%
1Y
3.6%
Sanai Health Industry Group
Market Cap: HK$47.4m
An investment holding company, engages in the manufacture, marketing, and sale of branded prescription and non-prescription drugs, as well as Chinese pharmaceutical products in the People’s Republic of China and Hong Kong.
1889
HK$0.31
7D
1.6%
1Y
-57.2%